beats by dre Elan had disclosed in July that it was setting aside $206.3 million to resolve the investigation. The payment included a $97 million criminal fine. The Japanese drug maker Eisai also agreed to pay $11 million to resolve a civil case for off-label marketing of Zonegran after it bought rights to the drug from Elan in 2004, federal prosecutors said. dr dre beats The agreement with Eisai in June was revealed Wednesday when the Elan case was partly unsealed.Elan Pharmaceuticals, a United States subsidiary of Elan, is pleading guilty to a misdemeanor charge of misbranding in violation of the federal Food, Drug and Cosmetics Act. There was no criminal case against Eisai. The cases rose from a 2004 whistle-blower filing by Dr. Lee R. Chartock, a monster beats Massachusetts psychiatrist who said he had been courted by Elan, sent to a conference and asked to prescribe the drug for weight loss. Dr. Chartock will receive more than $10 million from the civil payment as a reward to encourage people to report illegal activity, the government said.John B.moncler Moriarty Jr., senior vice president and general counsel of Elan, said the company was pleased to reach the agreement and was committed to high ethical and legal standards. Robert M. Thomas Jr., a Boston lawyer and co-counsel for Dr. Chartock, said the drug industry had tried to ignore marketing abuses. “Even companies that are serious about compliance usually still have sales forces that are compensated based on the volume of drugs sold,” he said monster headphones in an interview Wednesday. “It doesn’t take long for salespeople and their supervisors to figure out creative ways to hit higher numbers. The problem is those are achieved by off-label marketing.Elan and Eisai are the latest in a string of drug companies over the last five years to settle cases involving what federal prosecutors contend are off-label marketing violations of the federal False Claims Act hip hop beats.